Skip to main content

Julian Parkhill, Carol Churcher, Harold Swerdlow, Jane Rogers, Peter Pohl, Marcus Benz, Christof von Kalle, Dirk Honold, Thomas Pohl

Premium
The Wellcome Trust Sanger Institute has appointed a new senior management team for DNA sequencing.
 
Julian Parkhill, head of the pathogen sequencing unit, has become director of sequencing. His role will be “to support the new management team, to give strategic direction, and to promote the important interactions between the institute’s faculty Investigators and the sequencing group,” according to the Sanger Institute.
 
Carol Churcher is the new head of sequencing operations. She is a senior manager in the pathogen sequencing unit and joined the institute when it was founded in 1993. Previously, she worked at the MRC Laboratory of Molecular Biology.
 
Harold Swerdlow has become head of sequencing technology. Until early 2006, he was senior director of research at Solexa, which became part of Illumina last year. Swerdlow holds a PhD in bioengineering from the University of Utah.
 
Jane Rogers, human sequencing and mapping project manager, left the Sanger Institute last year, according to an institute spokesperson. Rogers was also a member of the board of management.
 

 
Peter Pohl has become CEO of LifeCode, a new personal genomics spinoff from German sequencing service provider GATC Biotech (see feature article in this issue). He is also the CEO of GATC Biotech.
 
Pohl and Marcus Benz, GATC’s chief operating officer, are members of LifeCode’s board of directors. Christof von Kalle, a professor at the University of Freiburg, Germany; Dirk Honold, a professor at the University of Applied Science in Nuremberg, Germany; and Thomas Pohl, GATC’s CTO, are members of the company’s supervisory board, according to LifeCode’s website.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.